Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post... see more

TSXV:LBL.H - Post Discussion

Lattice Biologics Ltd > From a previous poster
View:
Post by nothinghere on Feb 03, 2021 12:00pm

From a previous poster

I follow the industry, known Guy since his Bacterin days. I'm a little long on Lattice for fun. Hey, Guy could get enough suckers in again to get this up. Lattice doesn't belong in that article/report as their total revenue (let alone soft tissue) is a fraction of others mentioned.

Let's review the facts:
2016-2017 - Lattice leaves AZ. Rumor is that they are barely able to get their equipment out before the facilities were padlocked

2018 - stock price bottoms out ($.002 USD), hasn't recovered since (multiple failed growth campaigns)

2019 - slight glimmer of growth and stability in bone products

(Pre-pandemic) 2020 - decreased margins, Guy converts about $1M of debt owed to him by the company into stock.

March 2020 - stock pump scheme around unsupported claims with Amnioboost and Covid

July 2020 - FDA guidance released that amniotic fluid is no longer regulated as a 361 product. This essentially makes Lattice's only potential source of growth non-investable

September 2020 - FDA warning letter issued. Rumor is that they cannot sell legally into the state of FL (check certifications on their website)

 


You have to respect his tenacity, but they call him Guy Crook for a reason ;)

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities